Bank of America’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-49,802
| Closed | -$184K | – | 6540 |
|
|
2017
Q4 | $184K | Buy |
49,802
+10,688
| +27% | +$39.5K | ﹤0.01% | 4681 |
|
|
2017
Q3 | $160K | Buy |
39,114
+749
| +2% | +$3.06K | ﹤0.01% | 4720 |
|
|
2017
Q2 | $142K | Buy |
38,365
+837
| +2% | +$3.1K | ﹤0.01% | 4733 |
|
|
2017
Q1 | $155K | Buy |
37,528
+35,975
| +2,316% | +$149K | ﹤0.01% | 4709 |
|
|
2016
Q4 | $7K | Buy |
1,553
+1,345
| +647% | +$6.06K | ﹤0.01% | 5856 |
|
|
2016
Q3 | $2K | Sell |
208
-8,843
| -98% | -$85K | ﹤0.01% | 6088 |
|
|
2016
Q2 | $51K | Buy |
9,051
+8,676
| +2,314% | +$48.9K | ﹤0.01% | 5034 |
|
|
2016
Q1 | $3K | Sell |
375
-3,145
| -89% | -$25.2K | ﹤0.01% | 5891 |
|
|
2015
Q4 | $46K | Buy |
3,520
+1,288
| +58% | +$16.8K | ﹤0.01% | 5102 |
|
|
2015
Q3 | $37K | Sell |
2,232
-1,044
| -32% | -$17.3K | ﹤0.01% | 5076 |
|
|
2015
Q2 | $73K | Buy |
3,276
+3,048
| +1,337% | +$67.9K | ﹤0.01% | 4778 |
|
|
2015
Q1 | $2K | Sell |
228
-369
| -62% | -$3.24K | ﹤0.01% | 5692 |
|
|
2014
Q4 | $7K | Sell |
597
-295
| -33% | -$3.46K | ﹤0.01% | 5515 |
|
|
2014
Q3 | $10K | Buy |
892
+683
| +327% | +$7.66K | ﹤0.01% | 5464 |
|
|
2014
Q2 | $5K | Sell |
209
-148
| -41% | -$3.54K | ﹤0.01% | 5749 |
|
|
2014
Q1 | $6K | Sell |
357
-1,108
| -76% | -$18.6K | ﹤0.01% | 5433 |
|
|
2013
Q4 | $15K | Buy |
1,465
+581
| +66% | +$5.95K | ﹤0.01% | 5306 |
|
|
2013
Q3 | $11K | Sell |
884
-19,433
| -96% | -$242K | ﹤0.01% | 5299 |
|
|
2013
Q2 | $192K | Buy |
+20,317
| New | +$192K | ﹤0.01% | 4425 |
|